subject area of
- A mutation in the translation initiation codon of Gata-1 disrupts megakaryocyte maturation and causes thrombocytopenia Academic Article
- Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study Academic Article
- Clinical correlates of severe thrombocytopenia from temozolomide in glioblastoma patients Academic Article
- Dose Escalation Study of Carboplatin and Cyclophosphamide With Filgrastim Support Academic Article
- Enhancement of Platelet Recovery After Myelosuppressive Chemotherapy by Recombinant Human Megakaryocyte Growth and Development Factor in Patients With Advanced Cancer Academic Article
- Evidence of Platelet Activation at Medically Used Hypothermia and Mechanistic Data Indicating ADP as a Key Mediator and Therapeutic Target Academic Article
- Fli-1 Is Required for Murine Vascular and Megakaryocytic Development and Is Hemizygously Deleted in Patients with Thrombocytopenia Academic Article
- Hematopoietic abnormalities in mice deficient in gp130-mediated STAT signaling Academic Article
- Mitomycin C, Carboplatin and Protracted Venous Infusion 5-Fluorouracil in Advanced Oesophago–gastric and Pancreatic Cancer: Results of Two Phase II Studies Academic Article
- Mutations in the cofilin partner Aip1/Wdr1 cause autoinflammatory disease and macrothrombocytopenia Academic Article
- Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer. Academic Article
- Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia Academic Article
- Platelet growth factors: potential impact on transfusion medicine Academic Article
- Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling Academic Article
- Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer Academic Article